β1-Adrenoceptor, but not β2-adrenoceptor, subtype regulates heart rate in type 2 diabetic rats in vivo

Experimental Physiology

Volumn 102, Issue 8, 2017, Pages 911-923

  Cook, Rosalind F ^a   Bussey, Carol T ^a   Mellor, Kimberley M ^b   Cragg, Patricia A ^a   Lamberts, Regis R ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

heart rate regulation; type 2 diabetes; adrenoceptors

Indexed keywords

ATENOLOL; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; FENOTEROL; ISOPRENALINE; NADOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; CHRONOTROPISM; CONTROLLED STUDY; DRUG MEGADOSE; HEART RATE; HEMODYNAMICS; IN VIVO STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RAT; RESTING HEART RATE; VASCULAR ACCESS; ANIMAL; BLOOD PRESSURE; DISEASE MODEL; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; HEART CONTRACTION; MALE; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; ZUCKER RAT;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ATENOLOL; BLOOD PRESSURE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; HEART RATE; ISOPROTERENOL; MALE; MYOCARDIAL CONTRACTION; RATS; RATS, ZUCKER; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; SIGNAL TRANSDUCTION;

EID: 85020423256     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/EP086293     Document Type: Article

References (40)

1. Altan VM, Arioglu E, Guner S & Ozcelikay AT (2007). The influence of diabetes on cardiac β-adrenoceptor subtypes. Heart Fail Rev 12, 58–65.
2. 3-adrenoceptor stimulation in diabetic cardiomyopathy: the role of nitric oxide synthase 1-derived nitric oxide. Anesthesiology 107, 452–460.
3. 2-adrenergic receptor modulation of rate in sinoatrial myocytes. J Mol Cell Cardiol 42, 71–78.
4. Bidasee KR, Nallani K, Henry B, Dincer UD & Besch HR Jr (2003). Chronic diabetes alters function and expression of ryanodine receptor calcium-release channels in rat hearts. Mol Cell Biochem 249, 113–123.
5. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC & Stinson EB (1982). Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing human hearts. N Engl J Med 307, 205–211.
6. Brodde OE, Bruck H, Leineweber K & Seyfarth T (2001). Presence, distribution and physiological function of adrenergic and muscarinic receptor subtypes in the human heart. Basic Res Cardiol 96, 528–538.
7. Brubaker PH & Kitzman DW (2011). Chronotropic incompetence: causes, consequences, and management. Circulation 123, 1010–1020.
8. 2-adrenoceptor-regulated norepinephrine overflow in failing hearts from Zucker diabetic fatty rats. J Cardiovasc Pharmacol 47, 256–262.
9. Burger AJ, Weinrauch LA, D'Elia JA & Aronson D (1999). Effect of glycemic control on heart rate variability in type I diabetic patients with cardiac autonomic neuropathy. Am J Cardiol 84, 687–691.
10. Bussey CT, de Leeuw AE & Lamberts RR (2014a). Increased haemodynamic adrenergic load with isoflurane anaesthesia in type 2 diabetic and obese rats in vivo. Cardiovasc Diabetol 13, 161.
11. Bussey CT, Leeuw AE, Cook RF, Ashley Z, Schofield J & Lamberts RR (2014b). Dual implantation of a radio-telemeter and vascular access port allows repeated hemodynamic and pharmacological measures in conscious lean and obese rats. Lab Animals 48, 250–260.
12. Cole CR, Blackstone EH, Pashkow FJ, Snader CE & Lauer MS (1999). Heart-rate recovery immediately after exercise as a predictor of mortality. N Engl J Med 341, 1351–1357.
13. D'Souza A, Bucchi A, Johnsen AB, Logantha SJ, Monfredi O, Yanni J, Prehar S, Hart G, Cartwright E, Wisloff U, Dobryznski H, DiFrancesco D, Morris GM & Boyett MR (2014). Exercise training reduces resting heart rate via downregulation of the funny channel HCN4. Nat Commun 5, 3775.
14. 3-adrenoreceptors in rat hearts. Diabetes 50, 455–461.
15. Dinçer ÜD, Onay A, Ari N, Ozçelikay AT & Altan VM (1998). The effects of diabetes on β-adrenoceptor mediated responsiveness of human and rat atria. Diabetes Res Clin Pract 40, 113–122.
16. Durante W, Sunahara FA & Sen AK (1989). Alterations in atrial reactivity in a strain of spontaneously diabetic rats. Br J Pharmacol 97, 1137–1144.
17. Fredersdorf S, Thumann C, Ulucan C, Griese DP, Luchner A, Riegger GA, Kromer EP & Weil J (2004). Myocardial hypertrophy and enhanced left ventricular contractility in Zucker diabetic fatty rats. Cardiovasc Pathol 13, 11–19.
18. Giles WR (2005). Supraventricular pacemaker activity in the canine heart: contributions from HCN channels in control conditions and in a model of heart failure. Cardiovasc Res 66, 430–432.
19. Griffen SC, Wang J & German MS (2001). A genetic defect in β-cell gene expression segregates independently from the fa locus in the ZDF rat. Diabetes 50, 63–68.
20. Haas SJ, Vos T, Gilbert RE & Krum H (2003). Are beta-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials. Am Heart J 146, 848–853.
21. Haley JM, Thackeray JT, Kolajova M, Thorn SL & DaSilva JN (2015). Insulin therapy normalizes reduced myocardial β-adrenoceptors at both the onset and after sustained hyperglycemia in diabetic rats. Life Sci 132, 101–107.
22. Hasan W (2013). Autonomic cardiac innervation: development and adult plasticity. Organogenesis 9, 176–193.
23. Ho PM, Maddox TM, Ross C, Rumsfeld JS & Magid DJ (2008). Impaired chronotropic response to exercise stress testing in patients with diabetes predicts future cardiovascular events. Diabetes Care 31, 1531–1533.
24. Kannel WB, Kannel C, Paffenbarger RS Jr & Cupples LA (1987). Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 113, 1489–1494.
25. 1-adrenoceptor activation modulates intracellular oxygen availability. J Physiol 588, 2987–2998.
26. Logue JS & Scott JD (2010). Organizing signal transduction through A-kinase anchoring proteins (AKAPs). FEBS J 277, 4370–4375.
27. Malone MA, Schocken DD, Hanna SK, Liang X & Malone JI (2007). Diabetes-induced bradycardia is an intrinsic metabolic defect reversed by carnitine. Metabolism 56, 1118–1123.
28. Monfredi O, Maltsev VA & Lakatta EG (2013). Modern concepts concerning the origin of the heartbeat. Physiology (Bethesda) 28, 74–92.
29. Nauman J, Janszky I, Vatten LJ & Wisloff U (2011). Temporal changes in resting heart rate and deaths from ischemic heart disease. JAMA 306, 2579–2587.
30. 2-Adrenergic receptor redistribution in heart failure changes cAMP compartmentation. Science 327, 1653–1657.
31. Paulsen SJ, Vrang N, Larsen LK, Larsen PJ & Jelsing J (2010). Stereological assessment of pancreatic beta-cell mass development in male Zucker Diabetic Fatty (ZDF) rats: correlation with pancreatic beta-cell function. J Anat 217, 624–630.
32. 2-adrenergic receptor in rat ventricular muscle. Life Sci 88, 892–897.
33. Rengo G, Lymperopoulos A, Leosco D & Koch WJ (2011). GRK2 as a novel gene therapy target in heart failure. J Mol Cell Cardiol 50, 785–792.
34. 2-adrenergic receptor density. J Cardiovasc Electrophysiol 7, 1039–1049.
35. Schlaich MP, Sobotka PA, Krum H, Lambert E & Esler MD (2009). Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med 361, 932–934.
36. Seshadri N, Acharya N & Lauer MS (2003). Association of diabetes mellitus with abnormal heart rate recovery in patients without known coronary artery disease. Am J Cardiol 91, 108–111.
37. Takaya K, Ogawa Y, Isse N, Okazaki T, Satoh N, Masuzaki H, Mori K, Tamura N, Hosoda K & Nakao K (1996). Molecular cloning of rat leptin receptor isoform complementary DNAs—identification of a missense mutation in Zucker fatty (fa/fa) rats. Biochem Biophys Res Commun 225, 75–83.
38. Thaung HP, Baldi JC, Wang HY, Hughes G, Cook RF, Bussey CT, Sheard PW, Bahn A, Jones PP, Schwenke DO & Lamberts RR (2015). Increased efferent cardiac sympathetic nerve activity and defective intrinsic heart rate regulation in type 2 diabetes. Diabetes 64, 2944–2956.
39. Vinik AI & Ziegler D (2007). Diabetic cardiovascular autonomic neuropathy. Circulation 115, 387–397.
40. Wilson C & Lincoln C (1984). Beta-adrenoceptor subtypes in human, rat, guinea pig, and rabbit atria. J Cardiovasc Pharmacol 6, 1216–1221.